Thomas Christott
Impact in
-
- Protein Degradation and Inhibitors
- Histone Deacetylase Inhibitors Research
- Ubiquitin and proteasome pathways
- Cancer-related gene regulation
- Epigenetics and DNA Methylation
- Genomics and Chromatin Dynamics
- Chemical Synthesis and Analysis
-
- Acute Myeloid Leukemia Research
Papers in
-
- Protein Degradation and Inhibitors 3
- Ubiquitin and proteasome pathways 2
- Viral Infectious Diseases and Gene Expression in Insects 1
- Epigenetics and DNA Methylation 1
- S100 Proteins and Annexins 1
- Cancer-related gene regulation 1
-
- Radiopharmaceutical Chemistry and Applications 1
- Co-authors
- James M. Bennett (4 shared papers)Oleg Fedorov (4 shared papers)Charline Giroud (3 shared papers)Gillian Farnie (2 shared papers)C. Gileadi (2 shared papers)Octovia Monteiro (2 shared papers)Suet Ling Felce (1 shared paper)Rima Al‐awar (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (1 paper)ACS Medicinal Chemistry Letters (1 paper)SLAS DISCOVERY (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)
- Partner nations
- United KingdomGermanyUnited States
In The Last Decade
Thomas Christott
3 papers receiving 69 citations
Peers
Comparison fields: 5 of 18
- Molecular Biology 67
- Hematology 6
- Physical and Theoretical Chemistry 3
- Virology 1
- Oncology 4
Countries citing papers authored by Thomas Christott
This map shows the geographic impact of Thomas Christott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Christott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Christott more than expected).
Fields of papers citing papers by Thomas Christott
This network shows the impact of papers produced by Thomas Christott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Christott. The network helps show where Thomas Christott may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Christott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 42 | |
| 2 | 2019 | 21 | |
| 3 | 2023 | 6 | |
| 4 | 2024 | 0 |
About Thomas Christott
Thomas Christott is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Hematology, Cancer Research and Infectious Diseases, having authored 4 papers that have together received 69 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (3 papers), Ubiquitin and proteasome pathways (2 papers), Viral Infectious Diseases and Gene Expression in Insects (1 paper), Protease and Inhibitor Mechanisms (1 paper), Epigenetics and DNA Methylation (1 paper), S100 Proteins and Annexins (1 paper), Radiopharmaceutical Chemistry and Applications (1 paper) and Cancer-related gene regulation (1 paper). The work is most often cited by research in Molecular Biology (67 citations), Hematology (6 citations), Physical and Theoretical Chemistry (3 citations), Virology (1 citation) and Oncology (4 citations). Thomas Christott has collaborated with scholars based in United Kingdom, Germany and United States. Frequent co-authors include James M. Bennett, Oleg Fedorov, Charline Giroud, Gillian Farnie, C. Gileadi, Octovia Monteiro, Suet Ling Felce, Rima Al‐awar, Gennady Poda and Carmen Coxon. Their work appears in journals such as Journal of Medicinal Chemistry, ACS Medicinal Chemistry Letters, SLAS DISCOVERY and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.